Eye Care News: Recent News in Eye care


Eye care News Feed
- Ophthalmology Times spoke with Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis about how her research can align with human glaucoma research to move the entire field
- The pandemic caused an overall decrease in the rates of the 10 most common ophthalmic procedures performed in 2020 when compared to the year prior.
- Sunita Radhakrishnan, MD, shares insights on the use of electric neurostimulation and its potential use in the treatment of glaucoma, as evidenced by its current use in Europe and the upcoming trials for use in the US.
- Shan Lin, MD, speaks to the new MIGS entering the glaucoma space and providing additional options for patients and providers as they work to preserve vision and work towards a better future for glaucoma treatment options.
- Andrew Iwach, MD, co-founder of the Glaucoma 360 meeting shares that value this meeting has for residents and fellows as they embark on their careers and the future additions to the meeting that will include retina discussions.
- Inder Paul Singh, MD, speaks to the potential of artificial intelligence (AI) in the management of the glaucoma disease state as well as the current challenges of drug delivery in treating patients with glaucoma.
- John Berdahl, MD, discusses a non-surgical, non-drug treatment for glaucoma approved by the FDA in 2024. The pump uses negative pressure to lower eye pressure by an average of 39% in clinical trials, with a good safety profile.
- Andrew Iwach, MD, shares how Glaucoma 360 got its start and how today's meeting focuses on innovation that can benefit patients with glaucoma as the condition is monitored and treated.
- Sonia H. Yoo, MD, a cornea, cataract, and refractive surgery specialist and a member of the planning committee for the EnVision Summit, highlights a session focused on the latest advancements in lens implant technologies, refractive procedures, and imaging innovations. The summit will be held from February 14 to 17, 2025, at the Caribe Hilton San Juan in Puerto Rico.
- Researchers conducted a study to characterize ophthalmic adverse events associated with cosmetics and personal care products that have been reported in the FDA CAERS database.
- Patients commonly reported unexplained blurred or hazy vision postoperatively that requires further investigation
- From cytokine pathways to genomics, Shree Kurup, MD, highlights new approaches for managing diabetic retinopathy and combating systemic inflammation.
- Patients’ near visual needs is important when prescribing medications for glaucoma treatment
- EssilorLuxottica’s Nuance Audio glasses, which are equipped with hearing aids, will be available over the counter in the US and Europe as soon as Q1 2025.
- This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after 6 months of treatment in a retrospective chart review that included 102 patients with nAMD who had had suboptimal responses to other anti-VEGF therapies.
- Real-world scenarios showcase a shift in treatment paradigms
- This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of 50 healthy controls
- From easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.
- Through its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring sustainable eye care for the future.
- Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a one-time, outpatient procedure, continuously delivering a customized formulation of ranibizumab over time.
- Etnia Barcelona, an independent eyewear brand, launches its new Vintage collection for the SS25 season, an ode to sophistication inspired by shapes and colors of great classics from past eras. […] This story Etnia Barcelona Vintage Collection for Spring-Summer 2025 – appears on The Optical Journal.
- The success of the Woodys ATELIER line has prompted the addition of six new models: 4 optical and 2 suns. These new frames maintain the essence that characterizes the line, […] This story Woodys ATELIER Line Grows – appears on The Optical Journal.
- Born in Paris. Loved worldwide. As one of the first influencers, over the decades, ELLE has shaped style and empowered women across the globe. Going beyond fashion, ELLE is a […] This story ELLE Eyewear: New Year – New Direction. – appears on The Optical Journal.
- For Autumn/Winter 25, LINDA FARROW is inspired by surrealist art, emphasising the extraordinary beauty of unexpected combinations of form, shape and texture. Whilst remaining true to the iconic DNA of […] This story LINDA FARROW – Autumn/Winter 25 – appears on The Optical Journal.
- Welcome to London — where the raw, artistic energy of the East meets the sophisticated, timeless elegance of the West. William Morris is born from this dynamic interplay, crafting eyewear […] This story William Morris – Choose Your London – appears on The Optical Journal.
- With the new Spring/Summer 2025 collection, Blackfin launches its latest campaign with a fresh visual language that is both bold and sophisticated, transforming the brand’s iconic features into an enchanting, […] This story Blackfin Spring/Summer 2025 collection – appears on The Optical Journal.
- John Seegers of Optician Works and Laramy-K, have graciously shared some of their awesome videos with us to share with you. John is one of the best trainers of opticians and his […] This story Teachable Tuesday – How To Use The Lensmeter – Parts, Focus and Setup of The Marco LM 101 – appears on The Optical Journal.
- Italian brand Ultra Limited is preparing to launch seven new models at MIDO 2025 — four optical frames and three sunglasses. The collection includes four models for women, two for […] This story Ultra Limited To Unveil New Eyeglasses And Sunglasses At MIDO – appears on The Optical Journal.
- REFORM offers style that bends and durability that lasts with a patented technology. Rooted in innovation, REFORM glasses are engineered with cutting-edge flexible materials that effortlessly reform to their original […] This story Bend Shape REFORM – appears on The Optical Journal.
- JACQUEMUS has entered an exclusive distribution agreement with 8 AGENCY to promote and sell their eyewear category across North America. This agreement encompasses the United States, Canada, and the Caribbean […] This story JACQUEMUS Eyewear Announces Distribution Agreement With 8 AGENCY – appears on The Optical Journal.
- Catch up on what happened in optometry during the week of February 3-February 7.
- Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.
- The dynamic muscle stimulation device is a noninvasive option for patients experiencing lower lid laxity and impaired blinking.
- The Sentinel Camera aims to address critical gaps in retinal disease screening by offering a portable device that captures high-quality images that require no dilation of the eye.
- The company sits at spot 43 for “its outstanding performance in areas including unit growth, financial strength and stability, and brand power."
- Annual reports of the occurrence of adverse effects associated with the use of cosmetics increased from 2006 to 2018, then decreased from 2018 to 2021.
- The gel addresses necrotic retinal cell death in dry age-related macular degeneration and geographic atrophy without requiring injections.
- Both patient and provider benefit from reduced contact lens wear cycles.
- Optical coherence tomography angiography (OCTA) was performed in all participants; the choroidal and retinal changes were examined and recorded.
- All QLS-111 concentrations and dose regimens in both Osprey and Apteryx trials “demonstrated excellent safety and tolerability,” according to the company.
- The goal of the agreement is to advance Eleva’s current programs into mid- and late-stage clinical development.
- C.Rex is the only MGIS technology on the market that allows for fully titratable 180-360 comprehensive intervention.
- FDA approves ranibizumab for the treatment of diabetic macular edema via continuous delivery implantSusvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a one-time, outpatient procedure, continuously delivering a customized formulation of ranibizumab over time.
- Results from the study assisted Notal Vision in receiving De Novo authorization from the US FDA for the SCANLY Home OCT in 2024.
- Wells Fargo, Kirkland & Ellis, and PricewaterHouse Coopers International Limited served as main advisors to VSP Vision on the acquisition.
- The partnership will allow Kendra Scott to open availability of its eye wear in the United States starting in September 2025.
Follow us in Facebook